INTRODUCING JMCC AS A SILVER PARTNER OF CANNABIS EUROPA

INTRODUCING JMCC AS A SILVER PARTNER OF CANNABIS EUROPA

Established in 2016, the Jamaican Medical Cannabis Corp. (JMCC) is the leading global provider of premium-quality Jamaican medical cannabis products and services to the world.

With corporate offices in Toronto, Canada and Montego Bay, Jamaica, JMCC combines Jamaica’s natural, year-round growing climate and unique cannabis varieties with an unswerving commitment to international quality, safety and security standards and state-of-the-science R&D, cultivation, processing, product manufacturing, packaging, warehousing and global distribution.

JMCC has an international reach. In the United Kingdom, JMCC is one of five medical cannabis providers to Project Twenty21, Europe’s largest medical cannabis study. The company has also signed supply agreements with Licensed Producers in Canada, as well as in Australia, Germany and Brazil. Already EU GMP and “organically grown” compliant, it will complete certification for both standards in Q3 2020.

JMCC is led by an international executive team with deep experience in highly regulated industries. In Jamaica, it cultivates through the JMCC Farmers’ Collective, a growers’ cooperative that is majority-owned by its farmer-members and to whom JMCC provides access to agronomic training and skills development, annual price and volume guarantees and access to a well-managed supply chain, as well as oversight and guidance in sustainability and organic cultivation.

This is just one part of JMCC’s commitment to Jamaica. Through the JMCC Foundation, 10% of annual net profits are invested over 10 years in an endowment to support local scientific, educational, environmental, and community support programs.

JMCC also recently launched JMCC Scientific — a new division dedicated to researching, developing, testing, and manufacturing innovative cannabis-based treatments for a range of medical conditions.

As an experienced cultivator and supplier of medical cannabis, JMCC will be joining Prohibition Partners LIVE to share insights gained through years of operation as a leading global medical cannabis provider.

Join Prohibition Partners LIVE on 22 – 23 June to discover the latest developments in the European cannabis sector, learn from our world-renowned speakers, and engage with our network of industry-leading professionals who are pushing boundaries in the cannabis space.

Super early bird tickets
now on sale!

Book Now x